Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.80p
   
  • Change Today:
      0.050p
  • 52 Week High: 12.10
  • 52 Week Low: 4.50
  • Currency: UK Pounds
  • Shares Issued: 6,332m
  • Volume: 15,626
  • Market Cap: £303.96m
  • RiskGrade: 268
  • Beta: 0.00

AGY Overview

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.

Key Personnel

CEO: Manuel Llobet
Chief Finance Officer: Shaun Furlong
Executive Chairman: Helge Weiner- Trapness
Independent Non-Executive Director: Tunde Otulana
Independent Non-Executive Director: Lawrence Allen Wang
Non-Executive Dir: Peter Jensen, Cheryl MacDiarmid, Anthony Parker , Zheqing Shen , David Ball

Contact Details

Address: Dominion Way, Worthing, West Sussex, United Kingdom, BN14 8SA
Phone: +44 (0) 1903 844 700
Fax: +44 (0) 1903 844 726
Website: http://www.allergytherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B02LCQ05

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 4.80p
Change Today 0.050p
% Change 1.05 %
52 Week High 12.10
52 Week Low 4.50
Volume 15,626
Shares Issued 6,332m
Market Cap £303.96m
Beta 0.00
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.35% below the market average15.35% below the market average15.35% below the market average15.35% below the market average15.35% below the market average
2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average
Price Trend
89.38% above the market average89.38% above the market average89.38% above the market average89.38% above the market average89.38% above the market average
81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average
Income Not Available
Growth
32.61% below the market average32.61% below the market average32.61% below the market average32.61% below the market average32.61% below the market average
64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 06-Oct-2026

Time Volume / Share Price
16:35 14,166 @ 4.80p
16:35 166 @ 4.80p
16:35 14,000 @ 4.80p
13:04 621 @ 4.50p
13:04 240 @ 5.00p

AGY Key Personnel

CEO Manuel Llobet

Top of Page